Company Sanofi

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 16:55:00 08/05/2026 BST			5-day change	1st Jan Change
73.10 ^EUR	-0.87%		-8.42%	-11.63%

05-08	A lot of noise, little impact?
05-08	Berenberg Calls for More Acquisitions from Sanofi; Estimates Updated	MT

Business description: Sanofi

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:

- pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases;

- human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas.

At the end of 2025, the group had 37 production sites worldwide.

Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).

Number of employees: 74,846

Sales by Activity: Sanofi

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Biopharma	-	-	41.21B	43.95B	46.23B
Consumer Healthcare	4.52B	5.14B	5.23B	-	-
Pharmaceuticals Excl. Consumer Healthcare	27.23B	31.34B	-	-	-
Vaccines	7.42B	8.9B	-	-	-
Others	-	7M	-	339M	487M

See all business segments

Geographical breakdown of sales: Sanofi

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
United States	14.38B	18.28B	18.51B	19.99B	22.18B
Rest of The World	7.85B	8.39B	13.46B	12.07B	9.66B
Europe (Excluding France)	-	-	8.01B	7.21B	7.46B
China	2.72B	3.12B	-	-	2.62B
France	-	-	2.38B	1.81B	1.71B
Europe (Excl. Russia)	9.76B	10B	-	-	-
Russia	575M	674M	-	-	-
Brazil	815M	927M	-	-	-
North America (Excluding United States)	-	-	704M	-	-
Japan	1.66B	1.61B	-	-	-

See all geographic segments

Executive Committee: Sanofi

Manager	Title	Age	Since
Belén Garijo López CEO	Chief Executive Officer	64	30/04/2026
François-Xavier Roger DFI	Director of Finance/CFO	64	31/03/2024
Houman Ashrafian CTO	Chief Tech/Sci/R&D Officer	51	10/09/2023
Madeleine Roach COO	Chief Operating Officer	42	30/09/2023
Thomas Kudsk Larsen IRC	Investor Relations Contact	52	14/03/2024

See SANOFI governance

Composition of the Board of Directors: Sanofi

Director	Title	Age	Since
Christophe Babule BRD	Director/Board Member	60	29/04/2019
Rachel Duan BRD	Director/Board Member	56	27/04/2020
Lise Kingo BRD	Director/Board Member	64	27/04/2020
Barbara Lavernos BRD	Director/Board Member	58	29/04/2021
Wolfgang Laux BRD	Director/Board Member	58	31/03/2021
Carole Ferrand BRD	Director/Board Member	55	02/05/2022
Emile Voest BRD	Director/Board Member	66	02/05/2022
Antoine Yver BRD	Director/Board Member	68	02/05/2022
Frédéric Oudéa CHM	Chairman	62	24/05/2023
Anne-Francoise Nesmes BRD	Director/Board Member	55	29/04/2024

Composition of the Board of Directors

Shareholders: Sanofi

Name	Equities	%	Valuation
L'ORÉAL 7.315 %	88,670,657	7.315 %	8 451 M €
SANOFI 0.9869 %	11,962,777	0.9869 %	1 140 M €
OFI Invest Asset Management SA 0.2864 %	3,472,103	0.2864 %	331 M €
Goldman Sachs Asset Management International 0.1959 %	2,374,347	0.1959 %	226 M €
Goldman Sachs Asset Management BV 0.1743 %	2,112,507	0.1743 %	201 M €

Name	Equities	%	Valuation
Dodge & Cox 2.33 %	56,492,599	2.33 %	2 722 M €
Fisher Asset Management LLC 0.472 %	11,442,163	0.472 %	551 M €
Eaton Vance Management 0.3754 %	9,102,196	0.3754 %	439 M €
Merrill Lynch International 0.3524 %	8,544,008	0.3524 %	412 M €
Barrow, Hanley, Mewhinney & Strauss LLC 0.2874 %	6,968,413	0.2874 %	336 M €

List of SANOFI shareholders

Holdings: Sanofi

Name	Equities	%	Valuation
SANOFI 0.99%	11,962,777	0.99%	1 140 M $
SANOFI 60.4%	13,909,587	60.4%	630 M $
SANOFI INDIA LIMITED 60.4%	13,909,587	60.4%	470 M $
MEIRAGTX HOLDINGS PLC 15.15%	12,197,737	15.15%	106 M $
MEIRAGTX HOLDINGS PLC 7.93%	1,157,926	7.93%	78 M $
NOVAVAX, INC. 4.22%	6,880,481	4.22%	56 M $
ANAPTYSBIO, INC. 2.86%	821,917	2.86%	46 M $
EUROAPI 29.6%	28,298,074	29.6%	43 M $
SENSORION 13.87%	71,428,571	13.87%	33 M $
AGOMAB THERAPEUTICS NV 5.71%	2,783,096	5.71%	29 M $

Company details: Sanofi

Sanofi

46, avenue de la Grande Armée

75017, Paris

+33 1 53 77 40 00

http://www.sanofi.com

Group companies: Sanofi

Name	Category and Sector
SANOFI INDIA LIMITED	Pharmaceuticals: Major
SANOFI INDIA LIMITED	Pharmaceuticals: Major
Sanofi Healthcare India Pvt Ltd. Sanofi Healthcare India Pvt Ltd. BiotechnologyHealth Technology Develops and manufactures vaccines	Biotechnology
Sanofi Aventis Paraguay SA
Sanofi Manufacturing Pte Ltd.

See all subsidiaries

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
SANOFI	-0.87%	-8.42%	-20.34%	-27.09%	103B
ELI LILLY AND COMPANY	-2.72%	-1.54%	+26.22%	+119.18%	846B
JOHNSON & JOHNSON	-0.53%	-2.58%	+42.18%	+36.36%	533B
ABBVIE INC.	-0.57%	-2.44%	+8.61%	+36.69%	356B
ROCHE HOLDING AG	-0.94%	-0.97%	+21.32%	+10.98%	324B
ASTRAZENECA PLC	+0.23%	-1.24%	+31.68%	+11.93%	282B
NOVARTIS AG	+0.05%	-2.19%	+24.42%	+20.97%	278B
MERCK & CO., INC.	-0.82%	-0.70%	+43.44%	-5.91%	275B
NOVO NORDISK A/S	-1.76%	+4.42%	-32.32%	-49.34%	203B
AMGEN INC.	+0.79%	+0.57%	+21.93%	+41.38%	179B
Average	-0.49%	-1.51%	+16.71%	+19.51%	337.9B
Weighted average by Cap.	-0.78%	-1.48%	+22.95%	+41.13%